Which hedge funds own IONS? IONIS PHARMACEUTICALS INC, Q2 2026 13F holders
64 tracked hedge funds disclosed a position in IONS (IONIS PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $2.1bn in total. The largest holder by portfolio weight is Tweedy, Browne at 13.7% of its book. 10 opened a new position this quarter: Eagle Health Investments LP, Freestone Grove Partners LP, Militia Capital Management LLC, Y-Intercept (Hong Kong) Ltd. 13 exited: Ikarian Capital, LLC, Ground Swell Capital, LLC, Integral Health Asset Management, LLC.
- 64
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 10
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 13
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $53.9m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $31.4m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $2.1bn
- Combined value Sum of the holders' reported positions in the security.
- 5.2%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Ikarian Capital, LLC | 1.4% | $9.5m |
| Ground Swell Capital, LLC | 1.1% | $547k |
| Integral Health Asset Management, LLC | 0.5% | $9.4m |
| Stempoint Capital LP | 0.4% | $2.0m |
| Prelude Capital Management, LLC | 0.2% | $2.2m |
| Landscape Capital Management, L.L.C. | 0.10% | $1.5m |
| Readystate Asset Management LP | 0.09% | $1.5m |
| EntryPoint Capital, LLC | 0.07% | $222k |
| Bayforest Capital Ltd | 0.03% | $31.0k |
| Tudor Investment Corp ET AL | 0.02% | $3.6m |
| Lighthouse Investment Partners, LLC | 0.01% | $373k |
| Farallon Capital Management, L.L.C. | 0.0% | $360k |
| Elequin Capital, LP | 0.0% | $15.6k |
Ownership over time
Who discovered IONS first? Beta
The run: Q2 2016 → Q1 2019, +249%
| Great Point Partners LLC high conviction | Q4 2024 | – | +7.7 pts |
| First Light Asset Management, LLC high conviction | Q3 2018 | – | +2.2 pts |
| PDT Partners, LLC | Q3 2018 | – | +0.9 pts |
| Teza Capital Management LLC | Q1 2020 | – | +0.3 pts |
| EcoR1 Capital, LLC | Q4 2018 | – | 0.0 pts |
| Soleus Capital Management, L.P. | Q2 2020 | – | −0.3 pts |
| Parkman Healthcare Partners LLC | Q2 2022 | – | −0.4 pts |
| Caption Management, LLC | Q2 2020 | – | −0.4 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.